ProfileGDS4284 / 237675_at
TitleChronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood
OrganismHomo sapiens


control 0.2 mg/kg 1 mg/kg 2 mg/kg 4 mg/kg 6 mg/kg pre-treatment 24 hrs 4 wks 24 hrs 4 wks 24 hrs 4 wks 4 hrs 24 hrs 4 wks 4 hrs 24 hrs 4 wks 401 402 403 404 411 422 424 425 427 428 441 443 444 448 449 450 451 452 401 402 411 402 411 422 403 424 427 403 424 427 428 449 450 425 428 443 444 449 450 425 428 443 449 450 404 448 451 452 404 441 448 451 452 451 452 GSM687644 GSM687648 GSM687653 GSM687658 GSM687663 GSM687668 GSM687673 GSM687678 GSM687683 GSM687688 GSM687695 GSM687699 GSM687704 GSM687707 GSM687712 GSM687719 GSM687724 GSM687728 GSM687646 GSM687649 GSM687665 GSM687651 GSM687667 GSM687670 GSM687671 GSM687654 GSM687675 GSM687685 GSM687656 GSM687677 GSM687687 GSM687692 GSM687716 GSM687722 GSM687680 GSM687690 GSM687700 GSM687705 GSM687714 GSM687721 GSM687682 GSM687694 GSM687702 GSM687718 GSM687723 GSM687661 GSM687710 GSM687726 GSM687730 GSM687660 GSM687697 GSM687709 GSM687725 GSM687729 GSM687727 GSM687731 32% 18% 29% 34% 30% 24% 33% 32% 25% 6% 1% 26% 43% 29% 38% 22% 2% 24% 5% 7% 12% 5% 3% 23% 24% 19% 13% 14% 32% 22% 24% 44% 7% 30% 22% 25% 28% 11% 26% 2% 36% 25% 26% 1% 23% 6% 26% 20% 48% 30% 6% 28% 31% 2% 19% 15% sort by dose sort by time sort by individual Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM687644Patient 401 control79.795932
GSM687648Patient 402 control32.510718
GSM687653Patient 403 control71.419429
GSM687658Patient 404 control100.6734
GSM687663Patient 411 control86.047830
GSM687668Patient 422 control54.143924
GSM687673Patient 424 control101.01733
GSM687678Patient 425 control94.426432
GSM687683Patient 427 control65.886925
GSM687688Patient 428 control9.815136
GSM687695Patient 441 control9.248481
GSM687699Patient 443 control73.079826
GSM687704Patient 444 control150.37343
GSM687707Patient 448 control92.465629
GSM687712Patient 449 control124.1138
GSM687719Patient 450 control55.869922
GSM687724Patient 451 control7.420632
GSM687728Patient 452 control61.250724
GSM687646Patient 401 treated 24h10.15885
GSM687649Patient 402 treated 24h10.17487
GSM687665Patient 411 treated 24h23.68312
GSM687651Patient 402 treated 4 weeks10.67195
GSM687667Patient 411 treated 4 weeks8.521143
GSM687670Patient 422 treated 24h51.352123
GSM687671Patient 422 treated 4 weeks52.174424
GSM687654Patient 403 treated 24h32.129619
GSM687675Patient 424 treated 24h24.871213
GSM687685Patient 427 treated 24h23.164314
GSM687656Patient 403 treated 4 weeks76.276432
GSM687677Patient 424 treated 4 weeks46.687222
GSM687687Patient 427 treated 4 weeks47.451724
GSM687692Patient 428 treated 4h159.75344
GSM687716Patient 449 treated 4h13.83757
GSM687722Patient 450 treated 4h95.584930
GSM687680Patient 425 treated 24h45.13522
GSM687690Patient 428 treated 24h57.373525
GSM687700Patient 443 treated 24h108.83528
GSM687705Patient 444 treated 24h17.170511
GSM687714Patient 449 treated 24h55.574526
GSM687721Patient 450 treated 24h6.748292
GSM687682Patient 425 treated 4 weeks104.76136
GSM687694Patient 428 treated 4 weeks53.656525
GSM687702Patient 443 treated 4 weeks69.013726
GSM687718Patient 449 treated 4 weeks4.803751
GSM687723Patient 450 treated 4 weeks53.974323
GSM687661Patient 404 treated 4h12.86066
GSM687710Patient 448 treated 4h60.029326
GSM687726Patient 451 treated 4h45.677720
GSM687730Patient 452 treated 4h391.17848
GSM687660Patient 404 treated 24h102.50130
GSM687697Patient 441 treated 24h17.43966
GSM687709Patient 448 treated 24h76.834928
GSM687725Patient 451 treated 24h107.10731
GSM687729Patient 452 treated 24h10.14822
GSM687727Patient 451 treated 4 weeks44.751419
GSM687731Patient 452 treated 4 weeks29.775115